Saudi Food and Drug Authority Denies Camel Urine Product as Cancer Treatment
What happened
On October 19, 2026, the Saudi Food and Drug Authority (SFDA) clarified that a camel urine-derived product is registered solely as a dietary supplement, not as a cancer treatment.
The Context
- Regulatory clarity: The SFDA's statement directly addressed and debunked social media rumors about the product's efficacy in treating cancer.
- Cultural background: Traditional use of camel urine in the region has led to anecdotal claims of health benefits, including cancer treatment, despite a lack of scientific support.
- Public health messaging: The SFDA emphasized the importance of distinguishing between dietary supplements and approved medical treatments to protect consumer health.
The Number
— This is the number of cancer patients observed in a 2020-2022 study who used camel urine or milk, with no clinical benefits noted and two cases of brucellosis reported. This highlights the risks associated with unverified health claims.
Takeaway
Expect continued scrutiny of traditional remedies as health authorities reinforce the importance of evidence-based treatments.
English-language reporting on Saudi politics, policy, and society.
"Saudi Gazette reflects mainstream Saudi institutional perspectives."
— A47 Editor
SFDA debunks claims of approved camel urine-derived cancer treatment
The Saudi Food and Drug Authority (SFDA) has refuted claims regarding the approval of a cancer treatment derived from camel urine, clarifying that the product is merely a dietary supplement without therapeutic claims. This clarification comes amidst ...
English-language reporting focused on Saudi Arabia and regional affairs.
"Saudi Gazette provides English-language coverage that often aligns with mainstream Saudi news priorities."
— A47 Editor
SFDA debunks claims of approved camel urine-derived cancer treatment
The Saudi Food and Drug Authority (SFDA) has refuted claims regarding the approval of a cancer treatment derived from camel urine, clarifying that the product is merely a dietary supplement without therapeutic claims. This clarification comes amidst ...
Arabic-language reporting focused on Saudi domestic affairs and current events.
"Al Watan is a mainstream Saudi newspaper with strong domestic coverage and a broad general-news profile."
— A47 Editor
الغذاء والدواء: منتج بول الإبل ليس علاجا للسرطان
The Saudi Food and Drug Authority has denied claims that a product derived from camel urine has been approved as a treatment for cancer, clarifying that it is registered as a dietary supplement containing vitamins and minerals for daily nutritional n...
Arabic-language reporting focused on domestic developments in Saudi Arabia.
"Okaz is a mainstream Saudi newspaper that often reflects domestic priorities and official-facing coverage."
— A47 Editor
«الغذاء والدواء» تنفي اعتماد دواء مستخلص من بول الإبل لعلاج السرطان
The Saudi Food and Drug Authority has denied claims that a medication derived from camel urine has been approved for the treatment of cancer, stating that such assertions are false. The authority clarified that the product in question is registered a...